X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NCNA

Closed

Nucana Plc

0.0605
+0.0031 (+5.40%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 0.0574
Day's Range: 0.0575 - 0.0666
Send
When Written:
 
0.89
NuCana PLC is a clinical-stage biopharmaceutical company that focuses on developing and commercializing transformative medicines to treat cancer and other serious diseases. The company's proprietary ProTide technology platform transforms existing nucleoside analogs into novel drugs with enhanced efficacy and safety profiles.

NuCana's lead product candidate, Acelarin, is in Phase III clinical trials for the treatment of biliary tract cancer and in Phase II clinical trials for the treatment of ovarian cancer and pancreatic cancer. The company also has several other product candidates in preclinical and clinical development, including NUC-3373 for the treatment of colorectal cancer and NUC-7738 for the treatment of solid tumors.

NuCana was founded in 2008 and is headquartered in Edinburgh, Scotland, with additional offices in London and the United States. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol NCNA.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X